Tocilizumab ELISA Kit

PRINCIPLE OF THE ASSAY This assay employs the quantitative competitive enzyme immunoassay technique. Recombinant Human IL6R has been pre-coated onto a microplate. Standards or samples are premixed with biotin-labeled antibody and then pipetted into the wells. Tocilizumab in the sample competitively binds to the pre-coated protein with biotin-labeled Tocilizumab. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in inversely proportion to the amount of Tocilizumab bound in the initial step. The color development is stopped and the intensity of the color is measured.

Atlizumab, MRA / R-1569 / RHPM-1 / RO-4877533, CAS: 375823-41-9

Used for the quantitative determination of Tocilizumab concentration in serum and plasma.

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 20% prior to the expiration date under appropriate storage condition.

2-8 °C

For Research Use Only.